Your browser doesn't support javascript.
loading
Role of inflammasomes in endothelial dysfunction.
Wu, Jimin; Shyy, Melody; Shyy, John Y-J; Xiao, Han.
Afiliação
  • Wu J; Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.
  • Shyy M; State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.
  • Shyy JY; Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, China.
  • Xiao H; Research Unit of Medical Science Research Management/Basic and Clinical Research of Metabolic Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.
Br J Pharmacol ; 2024 Jul 01.
Article em En | MEDLINE | ID: mdl-38952037
ABSTRACT
The vascular endothelium dynamically responds to environmental cues and plays a pivotal role in maintaining vascular homeostasis by regulating vasomotor tone, blood cell trafficking, permeability and immune responses. However, endothelial dysfunction results in various pathological conditions. Inflammasomes are large intracellular multimeric complexes activated by pathogens or cellular damage. Inflammasomes in vascular endothelial cells (ECs) initiate innate immune responses, which have emerged as significant mediators in endothelial dysfunction, contributing to the pathophysiology of an array of diseases. This review summarizes the mechanisms and ramifications of inflammasomes in ECs and related vascular diseases such as atherosclerosis, abdominal aortic aneurysm, stroke, and lung and kidney diseases. We also discuss potential drugs targeting EC inflammasomes and their applications in treating vascular diseases.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Br J Pharmacol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Br J Pharmacol Ano de publicação: 2024 Tipo de documento: Article